Carrie Giordano, DO
Obstetrics & Gynecology · Kihei, HINPI 1205892072
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,181 of the $1,673 with a category attached, or 70.6%. 12 manufacturers reported payments, led by Novo Nordisk at 41.1% of the total. Reporting peaked in 2023 at $739 and has fallen 83.3% since, to $123 in 2025.
Across 51 payments — averaging $32.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$688
- Hologic Sales And Service, LLC$598
- Lilly USA, LLC$111
- Covidien LP$59
- Bayer$52
- Amgen$30
- plus $133 from 6 others
What the payments were for
- Travel & lodging$45927%
- Food & beverage$1,18171%
- Education$322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 31 | $688 |
| Hologic Sales And Service, LLC | 4 | $598 |
| Lilly USA, LLC | 6 | $111 |
| Covidien LP | 1 | $59 |
| Bayer | 2 | $52 |
| Amgen | 1 | $30 |
| Mayne Pharma Commercial LLC | 1 | $29 |
| Exact Sciences | 1 | $23 |
| AbbVie | 1 | $23 |
| Johnson & Johnson | 1 | $23 |
| Organon | 1 | $20 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACESSA PROVU SYSTEM$139
- Saxenda$110
- RYBELSUS$105
How this compares
$1,673 in reported general payments places this provider in the 80th percentile of 225 obstetrics & gynecology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 44 | $6,525 |
| Estradiol (Twice Weekly)Estradiol | 28 | $2,368 |
| ProgesteroneProgesterone, Micronized | 32 | $1,719 |
| DottiEstradiol | 11 | $1,432 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Kihei
- Eesha BhattacharyyaKailua$66K
- Richard McCartinHonolulu$32K
- Tricia WrightHonolulu$22K
- Michael AaronoffWaipahu$17K
- Martin NewmanWailuku$14K
- Tricia SongWaipahu$11K
- Bradley SakaguchiHonolulu$11K
- Celeste AdrianWailuku$8K
- Harry YoshinoHonolulu$7K
- Lynette TsaiHonolulu$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.